1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10bActinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosisActive, not recruitingPhase 12026-03-10NCT06050356